Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs
Alexandra Francian,1 Kristine Mann,1,2 Max Kullberg1 1WWAMI Medical Education Program, 2Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA Abstract: Antitumor immunity in cancer patients is heavily modulated by cells of the innate immune system. Antigen-presentin...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f36cd28b9b71492689827efdd7a44527 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f36cd28b9b71492689827efdd7a44527 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f36cd28b9b71492689827efdd7a445272021-12-02T01:08:05ZComplement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs1178-2013https://doaj.org/article/f36cd28b9b71492689827efdd7a445272017-07-01T00:00:00Zhttps://www.dovepress.com/complement-c3-dependent-uptake-of-targeted-liposomes-into-human-macrop-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Alexandra Francian,1 Kristine Mann,1,2 Max Kullberg1 1WWAMI Medical Education Program, 2Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA Abstract: Antitumor immunity in cancer patients is heavily modulated by cells of the innate immune system. Antigen-presenting cells, including dendritic cells, macrophages, and B cells, initiate immune recognition of tumor antigen by displaying antigen to effector cells. Countering this immune stimulation are immunosuppressive cells which include M2 macrophages, N2 neutrophils, and myeloid-derived suppressor cells (MDSCs). To create effective cancer immunotherapies, it is critical that we can target these important cell types of the immune system with immunostimulatory compounds. A commonality of these cell types is the complement receptor, which recognizes pathogens that are bound to activated complement C3 in human blood. To target the complement receptor, we have created a liposome that has a small molecule, orthopyridyl disulfide (OPSS), conjugated to its surface. OPSS forms a disulfide bond with activated complement C3, which then targets liposomes for uptake by dendritic cells, macrophages, B cells, MDSCs, and neutrophils in human blood. Internalization is efficient and specific to cells that display the complement receptor. Liposomes are a versatile drug delivery device. Possible applications for this system include delivery of toll-receptor agonists or tumor antigen to antigen-presenting cells and delivery of immunostimulatory drugs to M2, N2, and MDSC immunosuppressive cells. Keywords: cancer immuno therapy, antigen-presenting cells, complement C3, nanoparticle, targeted delivery Francian AMann KKullberg MDove Medical PressarticleCancer immunotherapyAntigen Presenting CellsComplement C3NanoparticleTargeted DeliveryMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 5149-5161 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Cancer immunotherapy Antigen Presenting Cells Complement C3 Nanoparticle Targeted Delivery Medicine (General) R5-920 |
spellingShingle |
Cancer immunotherapy Antigen Presenting Cells Complement C3 Nanoparticle Targeted Delivery Medicine (General) R5-920 Francian A Mann K Kullberg M Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
description |
Alexandra Francian,1 Kristine Mann,1,2 Max Kullberg1 1WWAMI Medical Education Program, 2Department of Biological Sciences, University of Alaska Anchorage, Anchorage, AK, USA Abstract: Antitumor immunity in cancer patients is heavily modulated by cells of the innate immune system. Antigen-presenting cells, including dendritic cells, macrophages, and B cells, initiate immune recognition of tumor antigen by displaying antigen to effector cells. Countering this immune stimulation are immunosuppressive cells which include M2 macrophages, N2 neutrophils, and myeloid-derived suppressor cells (MDSCs). To create effective cancer immunotherapies, it is critical that we can target these important cell types of the immune system with immunostimulatory compounds. A commonality of these cell types is the complement receptor, which recognizes pathogens that are bound to activated complement C3 in human blood. To target the complement receptor, we have created a liposome that has a small molecule, orthopyridyl disulfide (OPSS), conjugated to its surface. OPSS forms a disulfide bond with activated complement C3, which then targets liposomes for uptake by dendritic cells, macrophages, B cells, MDSCs, and neutrophils in human blood. Internalization is efficient and specific to cells that display the complement receptor. Liposomes are a versatile drug delivery device. Possible applications for this system include delivery of toll-receptor agonists or tumor antigen to antigen-presenting cells and delivery of immunostimulatory drugs to M2, N2, and MDSC immunosuppressive cells. Keywords: cancer immuno therapy, antigen-presenting cells, complement C3, nanoparticle, targeted delivery |
format |
article |
author |
Francian A Mann K Kullberg M |
author_facet |
Francian A Mann K Kullberg M |
author_sort |
Francian A |
title |
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
title_short |
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
title_full |
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
title_fullStr |
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
title_full_unstemmed |
Complement C3-dependent uptake of targeted liposomes into human macrophages, B cells, dendritic cells, neutrophils, and MDSCs |
title_sort |
complement c3-dependent uptake of targeted liposomes into human macrophages, b cells, dendritic cells, neutrophils, and mdscs |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/f36cd28b9b71492689827efdd7a44527 |
work_keys_str_mv |
AT franciana complementc3dependentuptakeoftargetedliposomesintohumanmacrophagesbcellsdendriticcellsneutrophilsandmdscs AT mannk complementc3dependentuptakeoftargetedliposomesintohumanmacrophagesbcellsdendriticcellsneutrophilsandmdscs AT kullbergm complementc3dependentuptakeoftargetedliposomesintohumanmacrophagesbcellsdendriticcellsneutrophilsandmdscs |
_version_ |
1718403291832909824 |